Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyurea and Verapamil for Refractory Meningiomas
NCT00706810Phase 2Completed
- Sponsor
- University of Utah
- Start
- Dec 2007
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of hydroxyurea and verapamil in meningioma, sponsored by University of Utah. Primary endpoint: Serious Adverse Events at 2 years. Started Dec 2007; status: completed.
02
Drugs
hydroxyureaverapamil
03
Conditions
meningioma
Beyond the preview
Go deeper on NCT00706810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00706810.